Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'p53 and mdm2 proteins interaction inhibitor chiral'

Search results for: 'p53 and mdm2 proteins interaction inhibitor chiral'

Items 1-10 of 31

Page
per page
  1. Valproic acid sodium salt (Sodium valproate)
    A4099 Valproic acid sodium salt (Sodium valproate)
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      ≥8.35 mg/mL
  2. 4E1RCat
    B3697 4E1RCat
    Target: eIF4F
    Summary: Dual inhibitor of eIF4E:eIF4G and eIF4E:4E-BP1 interaction
      ≥23.85 mg/mL
  3. EPZ005687
    A4171 EPZ005687
     2 Citation
    Target: EZH2
    Summary: EZH2 inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥3.86 mg/mL
  4. Enzastaurin (LY317615)
    A1670 Enzastaurin (LY317615)
     2 Citation
    Target: PKC
    Summary: PKC beta inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥8.59 mg/mL
  5. LY2801653
    A3573 LY2801653
    Target: MET
    Summary: MET inhibitor
      ≥27.65 mg/mL
  6. RGFP966
    A8803 RGFP966
     4 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Specific HDAC3 inhibitor
      insoluble in H2O; ≥18.12 mg/mL
  7. CH5424802
    A8393 CH5424802
    Target: ALK
    Summary: ALK inhibitor,potent and ATP-competitive
  8. SNS-032 (BMS-387032)
    A1980 SNS-032 (BMS-387032)
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK inhibitor
      insoluble in H2O; ≥19.05 mg/mL
  9. MLN4924
    B1036 MLN4924
     5 Citation
    Target: NAE|Ubiquitin-activating Enzyme E1|SUMOylation
    Summary: NAE inhibitor
      ≥22.18 mg/mL
  10. Mitoxantrone HCl
    B2114 Mitoxantrone HCl
    Target: Pim|Topoisomerases|USP|HIV Integrases
    Summary: Topoisomerase II inhibitor, anti-neoplastic drug
      insoluble in EtOH; ≥51.53 mg/mL

Items 1-10 of 31

Page
per page